Arsenic inhibits myogenic differentiation and muscle regeneration.
Yen
Yuan-Peng
YP
Institute of Toxicology, National Taiwan University, Taipei, Taiwan.
Tsai
Keh-Sung
KS
Chen
Ya-Wen
YW
Huang
Chun-Fa
CF
Yang
Rong-Sen
RS
Liu
Shing-Hwa
SH
D000818:Animals; D000077237:Arsenic Trioxide; D001152:Arsenicals; D002454:Cell Differentiation / Q000187:drug effects*; D002470:Cell Survival / Q000187:drug effects; D002478:Cells, Cultured; D003402:Creatine Kinase / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D006131:Growth Inhibitors / Q000633:toxicity*; D006801:Humans; D015151:Immunoblotting; D007150:Immunohistochemistry; D051379:Mice; D018482:Muscle, Skeletal / Q000187:drug effects* / Q000502:physiology; D032446:Myoblasts / Q000166:cytology / Q000187:drug effects*; D010087:Oxides / Q000633:toxicity*; D010766:Phosphorylation / Q000187:drug effects; D051057:Proto-Oncogene Proteins c-akt / Q000378:metabolism; D012038:Regeneration / Q000187:drug effects* / Q000502:physiology; D038762:Ribosomal Protein S6 Kinases, 70-kDa / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects*
D001152:Arsenicals; D006131:Growth Inhibitors; D010087:Oxides; D051057:Proto-Oncogene Proteins c-akt; D038762:Ribosomal Protein S6 Kinases, 70-kDa; D003402:Creatine Kinase; D000077237:Arsenic Trioxide